Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

Vis graf over relationer
Previous reports have shown that the proteomic markers apolipoprotein A1, hepcidin, transferrin, inter-alpha trypsin IV internal fragment, transthyretin, connective-tissue activating protein 3 and beta-2 microglobulin may discriminate between a benign pelvic mass and ovarian cancer (OC). The aim was to determine if these serum proteomic biomarkers alone as well as in combination with age and serum CA125, could be helpful in triage of women with a pelvic mass.
OriginalsprogEngelsk
TidsskriftGynecologic Oncology
Vol/bind123
Udgave nummer2
Sider (fra-til)308-13
Antal sider6
ISSN0090-8258
DOI
StatusUdgivet - 2011

ID: 33230114